Pancreatic Cancer section

Pancreatic Cancer News & Features

Chemo- and immunotherapy combination is a promising treatment for pancreatic cancer

Chemo- and immunotherapy combination is a promising treatment for pancreatic cancer

Pancreatic cancer may potentially be safely and effectively treated with immunochemotherapy, according to recent research from a preclinical study.

BRCA-related tumors respond to olaparib

Olaparib, an experimental oral cancer drug, has shown an overall tumor response rate of 26% in advanced cancers associated with BRCA1 and BRCA2 mutations, according to recent research.

MicroRNAs can accurately identify pancreatic cancer

MicroRNAs can accurately identify pancreatic cancer

Increased expression of a microRNA (miRNA) panel seems highly accurate for diagnosis of pancreatic ductal adenocarcinoma (PDAC), according to a study published online.

Factors contributing to pancreatic cancer identified

Factors contributing to pancreatic cancer identified

New research that provides a better understanding of pancreatic cancer may help identify those people at increased risk.

People with a family history of pancreatic cancer at increased risk for developing the disease

People with a family history of pancreatic cancer at increased risk for developing the disease

Patients with a family history of pancreatic cancer may be at an increased risk for developing the disease.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs